Clinical Trials Browser

Phase 1/2 × Suspended × Genitourinary × Clear all

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06643494 2025-03-11

Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical

Phase 1/2 Suspended

100 enrolled

Genitourinary

Prostatic Neoplasms

NCT06059014 2025-02-24

PRadR

Phase 1/2 Suspended

48 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma

NCT00033956 2005-06-24

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

Phase 1/2 Suspended

48 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Hypotension, Melanoma

Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical

PRadR

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2